|
|
|
Info: Your browser does not accept cookies. If you want to put products into your cart and purchase them you need to enable cookies.
Browse
Hemophilia or Blood Coagulation Disorders Drug Pipeline Report
Detailed information on the current drug pipeline. This report provides insight into the pipeline status of hemophilia or blood coagulation disorders drugs by company and by stage as well as a summary of the latest news and developments in this area.
Digestive System - Constipation Drug Pipeline Report
Detailed information on the current drug pipeline. This report provides insight into the pipeline status of constipation drugs by company and by stage as well as a summary of the latest news and developments in this area.
Insulin Delivery Systems Market Analysis (2007-2010)
The report investigates the market for various devices used for delivering insulin, including syringes, pens, pumps, needle-free injectors and inhalers. It also takes into account pros and cons of each device and gives a detailed analysis on their fut
Pipeline Insight: Dyslipidemia
In-depth review of developmental drugs for the dyslipidemia market. Explores the commercial prospects of new agents against existing products, profiles unmet needs, and provides sales forecasts for the developmental agents to 2016.
Gastrointestinal (Stomach) Cancer Drug Pipeline Report
Detailed information on the current drug pipeline. This report provides insight into the pipeline status of gastrointestinal (stomach) cancer drugs by company and by stage as well as a summary of the latest news and developments in this area.
Stakeholder Insight: Osteoporosis
This report is based on a survey of 180 physicians across the seven major markets covering key issues in osteopenia and osteoporosis; including epidemiology, presentation, diagnosis and treatment trends, prescribing influences, and brand assessments.<
Digestive System - Indigestion Drug Pipeline Report
Detailed information on the current drug pipeline. This report provides insight into the pipeline status of indigestion drugs by company and by stage as well as a summary of the latest news and developments in this area.
Commercial Insight: Antidyslipidemics 2007
In-depth review of the current antidyslipidemics market. Explores the opportunities and threats of the seven major markets, key events that are likely to impact the performance of the antidyslipidemics, and provides sales forecasts to 2016.
Forecast Insight: Dyslipidemia
Analysis of the competitive landscape and the recent changes in antidyslipidemics across seven major markets. Explores the key events that are likely to impact the performance of the antidyslipidemics, and provides sales forecasts to 2017.
Commercial Insight: Antidiabetics 2007
In-depth analysis of the current status and future potential of the marketed antidiabetic drug classes. Drug classes covered include sulfonylureas, biguanides, insulin, TZDs, AGIs, prandial glucose regulators and Incretin Mimetics.
Forecast Model: Antidyslipidemics
Region-specific sales value and volume forecasts for marketed dyslipidemia brands and generics in the US, 5EU, and Japan from 2008 to 2017.
Obesity Drug Markets in the US and EU
This report explores the dynamics and drivers of the market for current and emerging obesity treatments. This report evaluates the performances and attributes of currently marketed products and highlights the most effective strategies for securing fut
|
